Key points are not available for this paper at this time.
particles/mL. As a proof of concept, this SERS platform was successfully applied to distinguish cervical cancer patients from healthy individuals by analyzing Exos in clinical serum samples, enabling early and noninvasive cancer diagnosis.
Diao et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: